195 related articles for article (PubMed ID: 34504642)
1. Protective Effect of Yi Shen Pai Du Formula against Diabetic Kidney Injury via Inhibition of Oxidative Stress, Inflammation, and Epithelial-to-Mesenchymal Transition in
Zhang Q; Liu X; Sullivan MA; Shi C; Deng B
Oxid Med Cell Longev; 2021; 2021():7958021. PubMed ID: 34504642
[TBL] [Abstract][Full Text] [Related]
2. PS-MPs promotes the progression of inflammation and fibrosis in diabetic nephropathy through NLRP3/Caspase-1 and TGF-β1/Smad2/3 signaling pathways.
Feng L; Chen C; Xiong X; Wang X; Li X; Kuang Q; Wei X; Gao L; Niu X; Li Q; Yang J; Li L; Luo P
Ecotoxicol Environ Saf; 2024 Mar; 273():116102. PubMed ID: 38382346
[TBL] [Abstract][Full Text] [Related]
3. NQO1 alleviates renal fibrosis by inhibiting the TLR4/NF-κB and TGF-β/Smad signaling pathways in diabetic nephropathy.
Qiu D; Song S; Chen N; Bian Y; Yuan C; Zhang W; Duan H; Shi Y
Cell Signal; 2023 Aug; 108():110712. PubMed ID: 37196773
[TBL] [Abstract][Full Text] [Related]
4. Astragaloside IV Alleviates Renal Tubular Epithelial-Mesenchymal Transition via CX3CL1-RAF/MEK/ERK Signaling Pathway in Diabetic Kidney Disease.
Hu Y; Tang W; Liu W; Hu Z; Pan C
Drug Des Devel Ther; 2022; 16():1605-1620. PubMed ID: 35669284
[TBL] [Abstract][Full Text] [Related]
5. Empagliflozin reduces high glucose-induced oxidative stress and miR-21-dependent TRAF3IP2 induction and RECK suppression, and inhibits human renal proximal tubular epithelial cell migration and epithelial-to-mesenchymal transition.
Das NA; Carpenter AJ; Belenchia A; Aroor AR; Noda M; Siebenlist U; Chandrasekar B; DeMarco VG
Cell Signal; 2020 Apr; 68():109506. PubMed ID: 31862399
[TBL] [Abstract][Full Text] [Related]
6. Complanatoside A targeting NOX4 blocks renal fibrosis in diabetic mice by suppressing NLRP3 inflammasome activation and autophagy.
Ren C; Bao X; Lu X; Du W; Wang X; Wei J; Li L; Li X; Lin X; Zhang Q; Ma B
Phytomedicine; 2022 Sep; 104():154310. PubMed ID: 35843189
[TBL] [Abstract][Full Text] [Related]
7. Tanshinone IIA mediates protection from diabetes kidney disease by inhibiting oxidative stress induced pyroptosis.
Wu Q; Guan YB; Zhang KJ; Li L; Zhou Y
J Ethnopharmacol; 2023 Nov; 316():116667. PubMed ID: 37257702
[TBL] [Abstract][Full Text] [Related]
8. Aerobic exercise training alleviates renal injury in db/db mice through inhibiting Nox4-mediated NLRP3 inflammasome activation.
Zhou Z; Ying C; Zhou X; Shi Y; Xu J; Zhu Y; Wang M; Li Y; Li X; Xiang J
Exp Gerontol; 2022 Oct; 168():111934. PubMed ID: 36007721
[TBL] [Abstract][Full Text] [Related]
9. Acetylshikonin from Zicao ameliorates renal dysfunction and fibrosis in diabetic mice by inhibiting TGF-β1/Smad pathway.
Li Z; Hong Z; Peng Z; Zhao Y; Shao R
Hum Cell; 2018 Jul; 31(3):199-209. PubMed ID: 29549584
[TBL] [Abstract][Full Text] [Related]
10. Amygdalin alleviates renal injury by suppressing inflammation, oxidative stress and fibrosis in streptozotocin-induced diabetic rats.
Chen J; Hu Y; Mou X; Wang H; Xie Z
Life Sci; 2021 Jan; 265():118835. PubMed ID: 33253723
[TBL] [Abstract][Full Text] [Related]
11. A bioinformatics and network pharmacology approach to the mechanisms of action of Shenxiao decoction for the treatment of diabetic nephropathy.
Mou X; Zhou DY; Zhou D; Liu K; Chen LJ; Liu WH
Phytomedicine; 2020 Apr; 69():153192. PubMed ID: 32200292
[TBL] [Abstract][Full Text] [Related]
12. Paricalcitol attenuates TGF-β1-induced phenotype transition of human peritoneal mesothelial cells (HPMCs) via modulation of oxidative stress and NLRP3 inflammasome.
Ko J; Kang HJ; Kim DA; Ryu ES; Yu M; Lee H; Lee HK; Ryu HM; Park SH; Kim YL; Kang DH
FASEB J; 2019 Feb; 33(2):3035-3050. PubMed ID: 30354670
[TBL] [Abstract][Full Text] [Related]
13. [Triptolide inhibits NLRP3 inflammasome activation and ameliorates podocyte epithelial-mesenchymal transition induced by high glucose].
Wu W; Liu BH; Wan YG; Sun W; Liu YL; Wang WW; Fang QJ; Tu Y; Yee HY; Yuan CC; Wan ZY
Zhongguo Zhong Yao Za Zhi; 2019 Dec; 44(24):5457-5464. PubMed ID: 32237395
[TBL] [Abstract][Full Text] [Related]
14. Huangkui capsule alleviates renal tubular epithelial-mesenchymal transition in diabetic nephropathy via inhibiting NLRP3 inflammasome activation and TLR4/NF-κB signaling.
Han W; Ma Q; Liu Y; Wu W; Tu Y; Huang L; Long Y; Wang W; Yee H; Wan Z; Tang R; Tang H; Wan Y
Phytomedicine; 2019 Apr; 57():203-214. PubMed ID: 30785016
[TBL] [Abstract][Full Text] [Related]
15. Yishen Tongluo formula alleviates diabetic kidney disease through regulating Sirt6/TGF-β1/Smad2/3 pathway and promoting degradation of TGF-β1.
Zhang X; Zhao L; Xiang S; Sun Y; Wang P; Chen JJ; Teo BS; Xie Z; Zhang Z; Xu J
J Ethnopharmacol; 2023 May; 307():116243. PubMed ID: 36791927
[TBL] [Abstract][Full Text] [Related]
16. Trigonelline inhibits tubular epithelial-mesenchymal transformation in diabetic kidney disease via targeting Smad7.
Gong M; Guo Y; Dong H; Wu W; Wu F; Lu F
Biomed Pharmacother; 2023 Dec; 168():115747. PubMed ID: 37864898
[TBL] [Abstract][Full Text] [Related]
17. Protective mechanism of traditional Chinese medicine guizhi fuling pills against carbon tetrachloride-induced kidney damage is through inhibiting oxidative stress, inflammation and regulating the intestinal flora.
Xu B; Zheng J; Tian X; Yuan F; Liu Z; Zhou Y; Yang Z; Ding X
Phytomedicine; 2022 Jul; 101():154129. PubMed ID: 35490491
[TBL] [Abstract][Full Text] [Related]
18. Alpha lipoamide inhibits diabetic kidney fibrosis via improving mitochondrial function and regulating RXRα expression and activation.
Zhang HF; Liu HM; Xiang JY; Zhou XC; Wang D; Chen RY; Tan WL; Liang LQ; Liu LL; Shi MJ; Zhang F; Xiao Y; Zhou YX; Zhang T; Tang L; Guo B; Wang YY
Acta Pharmacol Sin; 2023 May; 44(5):1051-1065. PubMed ID: 36347997
[TBL] [Abstract][Full Text] [Related]
19. Akebia Saponin D ameliorated kidney injury and exerted anti-inflammatory and anti-apoptotic effects in diabetic nephropathy by activation of NRF2/HO-1 and inhibition of NF-KB pathway.
Lu C; Fan G; Wang D
Int Immunopharmacol; 2020 Jul; 84():106467. PubMed ID: 32344355
[TBL] [Abstract][Full Text] [Related]
20. Huangkui capsule in combination with metformin ameliorates diabetic nephropathy via the Klotho/TGF-β1/p38MAPK signaling pathway.
Gu LY; Yun-Sun ; Tang HT; Xu ZX
J Ethnopharmacol; 2021 Dec; 281():113548. PubMed ID: 33152427
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
